News Sentiment

EPRX sentiment intelligence

Eupraxia Pharmaceuticals Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 6.68 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 43

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-0.1% over one week, +10.6% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Positive

Eupraxia Pharmaceuticals (EPRX) reshapes leadership and expands Vancouver-Seattle hubs

Market Reaction

Balanced read

54/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction -0.1% Price digesting
Trend fit Trend inactive 10.6% over four weeks
Fair value 41.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 32
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 43
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 11
Market source 8
GlobeNewswire 8
MT Newswires 3
simplywall.st 3
dars.gov.et 2
Quiver Quantitative 2
TIKR.com 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 18
Analyst action 2
Balance sheet 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 50